What the data says, in numbers.

Bar = min–max concordance for that item across the compared panels. Weakest items in most panels: CRP and GGT (75–82%).

Repeated sessions build a personal baseline: averaging several sessions matched the blood panel better than a single same-day reading, and trends persisted across weeks.

Korea

Blood panel vs CARNA — two-subject pilot

2 adults · 1 session each · 13 blood items

• Overall agreement 87.5% / 85.1%
• HDL-C 96.5–97.2%, glucose 93.1–95.8%, triglycerides 91.4–92.4%

Reference ranges normalized to 0–100; agreement = closeness of normalized scores.

Japan

Blood panel vs CARNA — male, 60s

1 adult · 1 session · 257 markers · 22 items compared (5 direct)

• Overall 82.3% · direct-match items 96.2%
• Bilirubin 96–98%, triglycerides 95.6%, glucose/HbA1c 93.1%, LDL-C 92.8%

Normal/abnormal interpretation match; complete = 100%, partial = 75–85%.

Japan

Blood panel vs CARNA — male, 60s

1 adult · 1 session · 257 markers · 19 items

• Overall 89.1% · direct-match 96.5–97.2%
• Liver enzyme & bilirubin items 98–99%, BUN 97%, creatinine 96%

Same method as above; mean discrepancy 10.9%.

Japan

Blood panel vs CARNA — female, 50s

1 adult · 1 session · 261 markers · 20 items

• Overall 81.6% · direct-match 94.7%
• Bilirubin 95–97%, triglycerides 93.8%, creatinine 92.1%

Mean discrepancy 18.4%.

Japan

Post-surgery recovery case — blood vs CARNA

1 adult (male, 60s) · ~3 months after surgery · 18 items

• Overall 85.9% · direct-match 96.4%
• 7 complete / 11 partial matches; HbA1c 95.9%, total cholesterol 94.2%

Complete ≥ 90%, partial ≥ 70% after normalization.

UAE

Blood panel vs 6 repeated sessions — female, 30s

1 adult · 6 sessions over 2 months · ~260 markers · 1 blood panel

• Direct items: same-day 87.6%, 6-session mean 84.3%
• Liver panel: 6-session mean 89.3% beat same-day 83.6%
• HbA1c 92.9%, creatinine 95.1%, total cholesterol 90.7%, B12 90.5%

Categorical (normal/low/high) and directional agreement, not numeric equality.

UAE

8-session longitudinal — male, 50s

1 adult · 8 sessions over 57 days · ~255 markers each

• Wellness index range 49.4–71.2; 5 same-window sessions mean 59.7
• Intra-individual CV: liver-fat index 6.9%, pH index 9.8%

Natural intraday variability of 10–20% expected; fixed measurement time and 2–3 h after meals recommended.

Indonesia

Group screening, users aged 50+

25 adults (50–82 y, mean 61.6) · 1 session each

• Wellness index mean 64.3 (50.8–75.4); 50s 67.8 vs 70+ 59.2
• 3.84 attention items per person; BMI mean 24.9

Descriptive population summary; no blood comparison.

Korea

4-session repeat — male, 50s

1 adult · 4 sessions over 2 months

• Wellness index 67.0 → 62.7 → 67.5 → 71.7; attention items 4/5/4/3

Persistent trends tracked across sessions (e.g. bone-turnover and vitamin D indices).

Korea

5-session repeat — male, 40s

1 adult (BMI 26.4) · 5 sessions over 4 weeks

• Wellness index 66.0 → 55.2 → 56.0 → 61.3 → 67.7 (+12.5 from low)
• Liver-fat index 7.2–8.9, pH index 31.3–37.0 — consistently out of range in all 5

Illustrates week-to-week trend sensitivity.

Korea

7-session repeat over 70 days — male, 30s

1 adult · 7 sessions · 258+ indicators

• Wellness score mean 62.0, SD 5.2, range 55.1–68.0
• Liver-fat index 7/7 sessions out of range (mean 7.88, SD 0.40)
• Morning vs afternoon score 63.8 vs 61.3; HR 88–92 bpm stable

Repeatability and time-of-day effect.

Korea

Consumer genetic test vs 14-session CARNA mean — female, 50s

1 adult · 14 sessions over 10 weeks · 16 items

• Mean agreement 76.9%; selenium 93.6%, iron 93.4%, vitamin D 92.9%
• Wellness index 58.9–77.8 across 14 sessions

Genetic risk tier mapped to a reference-range position; agreement = 100 − |difference|.